US 9101582
Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen
granted A61KA61K31/00A61K31/53
Quick answer
US patent 9101582 (Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen) held by The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention expires Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
- Grant date
- Tue Aug 11 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/00, A61K31/53, A61K38/164, A61K38/1725